SCHEMBL21849574

SCHEMBL21849574

CC(C)c1ncn(-c2cccc(Cl)c2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.44
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FGFR1 P11362 1/20 0.41
IDO1 P14902 1/20 0.41
PKM P14618 1/20 0.39
KDM5B Q9UGL1 1/20 0.38
HCAR1 Q9BXC0 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PARP1 P09874 1/20 0.38
PARP2 Q9UGN5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26029289 0.83 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HPGDL3MBTL1FGFR1
SCHEMBL19626764 0.80 NOTUM (0.42) NOTUMALDH1A1L3MBTL1MAPT
SCHEMBL21849777 0.80 NOTUM (0.48) NOTUMALDH1A1SMN1; SMN2HPGDFGFR1
SCHEMBL15980615 0.80 SMN1; SMN2 (0.44) NOTUMALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL16202012 0.79 NOTUM (0.47) NOTUMALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL23603987 0.78 GRM5 (0.55) NOTUM
SCHEMBL21849229 0.78 NOTUM (0.51) NOTUMALDH1A1
SCHEMBL10361336 0.76 NOTUM (0.47) NOTUMALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL21849284 0.75 NOTUM (0.47) NOTUMALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL13160181 0.75 NOTUM (0.51) NOTUMALDH1A1SMN1; SMN2L3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 US disclosed
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 US disclosed
US-20200102311-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242531-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NOTUM 824/4885ALDH1A1 344/4885SMN1; SMN2 3714/4885
US-20200102311-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NOTUM 824/4885ALDH1A1 344/4885SMN1; SMN2 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.